{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T08:08:41Z","timestamp":1761898121511,"version":"3.44.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T00:00:00Z","timestamp":1750723200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1007\/s12035-025-05145-4","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T18:44:10Z","timestamp":1750704250000},"page":"13636-13649","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Exploring the Potential Mechanism of Action of Ursolic Acid for Parkinson\u2019s Disease: An Integrative Network Pharmacology, Docking and Molecular Dynamics Study"],"prefix":"10.1007","volume":"62","author":[{"given":"Angel","family":"Godad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richa","family":"Sawant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akshata R","family":"Pahelkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Galvina","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sadhana","family":"Sathaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,24]]},"reference":[{"key":"5145_CR1","doi-asserted-by":"crossref","unstructured":"Hindle J (2020) Neurodegenerative disorders in older people. In: Firth J, Conlon C, Cox T (eds) Oxford Textbook of Medicine, 6th edn. Oxford University Press, Oxford, pp 601\u2013611","DOI":"10.1093\/med\/9780198746690.003.0061"},{"key":"5145_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21072464","volume":"21","author":"SJ Chia","year":"2020","unstructured":"Chia SJ, Tan E-K, Chao Y-X (2020) Historical perspective: models of Parkinson\u2019s disease. IJMS 21:2464. https:\/\/doi.org\/10.3390\/ijms21072464","journal-title":"IJMS"},{"key":"5145_CR3","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/4490081","volume":"2021","author":"D Lin","year":"2021","unstructured":"Lin D, Zeng Y, Tang D, Cai Y (2021) Study on the mechanism of Liuwei Dihuang pills in treating Parkinson\u2019s disease based on network pharmacology. Biomed Res Int 2021:4490081. https:\/\/doi.org\/10.1155\/2021\/4490081","journal-title":"Biomed Res Int"},{"key":"5145_CR4","doi-asserted-by":"publisher","DOI":"10.1155\/2021\/1752570","volume":"2021","author":"Y Liu","year":"2021","unstructured":"Liu Y, Yu L, Zhang J et al (2021) Network Pharmacology-based and molecular docking-based analysis of suanzaoren decoction for the treatment of Parkinson\u2019s disease with sleep disorder. Biomed Res Int 2021:1752570. https:\/\/doi.org\/10.1155\/2021\/1752570","journal-title":"Biomed Res Int"},{"key":"5145_CR5","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1177\/1756285609339382","volume":"2","author":"SJ Groiss","year":"2009","unstructured":"Groiss SJ, Wojtecki L, S\u00fcdmeyer M, Schnitzler A (2009) Review: Deep brain stimulation in Parkinson\u2019s disease. Ther Adv Neurol Disord 2:379\u2013391. https:\/\/doi.org\/10.1177\/1756285609339382","journal-title":"Ther Adv Neurol Disord"},{"key":"5145_CR6","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s10020-021-00279-2","volume":"27","author":"T Ntetsika","year":"2021","unstructured":"Ntetsika T, Papathoma P-E, Markaki I (2021) Novel targeted therapies for Parkinson\u2019s disease. Mol Med 27:17. https:\/\/doi.org\/10.1186\/s10020-021-00279-2","journal-title":"Mol Med"},{"key":"5145_CR7","doi-asserted-by":"publisher","unstructured":"Stoker TB (2018) Stem cell treatments for Parkinson\u2019s disease. In: Stoker TB, Greenland JC (eds) Parkinson\u2019s disease: pathogenesis and clinical aspects. Codon Publications. https:\/\/doi.org\/10.15586\/codonpublications.parkinsonsdisease.2018.ch9","DOI":"10.15586\/codonpublications.parkinsonsdisease.2018.ch9"},{"key":"5145_CR8","doi-asserted-by":"publisher","unstructured":"Manjeshwar Shrinath Baliga et al (2019) Phytochemicals in the prevention of ethanol-induced hepatotoxicity: a revisit. Dietary Interventions in Liver Disease 79\u201389. https:\/\/doi.org\/10.1016\/B978-0-12-814466-4.00007-0","DOI":"10.1016\/B978-0-12-814466-4.00007-0"},{"key":"5145_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fvets.2023.1251248","volume":"10","author":"G Liu","year":"2023","unstructured":"Liu G, Qin P, Cheng X et al (2023) Ursolic acid: biological functions and application in animal husbandry. Front Vet Sci 10:1251248. https:\/\/doi.org\/10.3389\/fvets.2023.1251248","journal-title":"Front Vet Sci"},{"key":"5145_CR10","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000032222","volume":"101","author":"B Yang","year":"2022","unstructured":"Yang B, Zhu Q, Wang X et al (2022) Using network pharmacology and molecular docking verification to explore the mechanism of ursolic acid in the treatment of osteoporosis. Medicine 101:e32222. https:\/\/doi.org\/10.1097\/MD.0000000000032222","journal-title":"Medicine"},{"key":"5145_CR11","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1007\/s12640-019-00038-6","volume":"36","author":"SN Rai","year":"2019","unstructured":"Rai SN, Zahra W, Singh SS et al (2019) Anti-inflammatory activity of ursolic acid in MPTP-induced parkinsonian mouse model. Neurotox Res 36:452\u2013462. https:\/\/doi.org\/10.1007\/s12640-019-00038-6","journal-title":"Neurotox Res"},{"key":"5145_CR12","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1080\/1028415X.2022.2051957","volume":"26","author":"C Chen","year":"2023","unstructured":"Chen C, Ai Q, Shi A et al (2023) Oleanolic acid and ursolic acid: therapeutic potential in neurodegenerative diseases, neuropsychiatric diseases and other brain disorders. Nutr Neurosci 26:414\u2013428. https:\/\/doi.org\/10.1080\/1028415X.2022.2051957","journal-title":"Nutr Neurosci"},{"key":"5145_CR13","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s40263-017-0474-4","volume":"31","author":"AB Ramos-Hryb","year":"2017","unstructured":"Ramos-Hryb AB, Pazini FL, Kaster MP, Rodrigues ALS (2017) Therapeutic potential of ursolic acid to manage neurodegenerative and psychiatric diseases. CNS Drugs 31:1029\u20131041. https:\/\/doi.org\/10.1007\/s40263-017-0474-4","journal-title":"CNS Drugs"},{"key":"5145_CR14","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1016\/j.toxrep.2020.04.005","volume":"7","author":"L Geerlofs","year":"2020","unstructured":"Geerlofs L, He Z, Xiao S, Xiao Z-C (2020) Repeated dose (90 days) oral toxicity study of ursolic acid in Han-Wistar rats. Toxicol Rep 7:610\u2013623. https:\/\/doi.org\/10.1016\/j.toxrep.2020.04.005","journal-title":"Toxicol Rep"},{"key":"5145_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.fct.2020.111537","volume":"144","author":"L Geerlofs","year":"2020","unstructured":"Geerlofs L, He Z, Xiao S, Xiao Z-C (2020) 15-Day subchronic developmental toxicity studies of ursolic acid in rats. Food Chem Toxicol 144:111537. https:\/\/doi.org\/10.1016\/j.fct.2020.111537","journal-title":"Food Chem Toxicol"},{"key":"5145_CR16","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1186\/s43094-020-00173-4","volume":"7","author":"V Mishra","year":"2021","unstructured":"Mishra V, Soren AD, Yadav AK (2021) Toxicological evaluations of betulinic acid and ursolic acid; common constituents of Houttuynia cordata used as an anthelmintic by the Naga tribes in North-east India. Futur J Pharm Sci 7:39. https:\/\/doi.org\/10.1186\/s43094-020-00173-4","journal-title":"Futur J Pharm Sci"},{"key":"5145_CR17","doi-asserted-by":"publisher","first-page":"100412","DOI":"10.1016\/j.chphi.2023.100412","volume":"8","author":"CB Olowosoke","year":"2024","unstructured":"Olowosoke CB, Eze CJ, Munir A et al (2024) Integrative study of phytochemicals for anti-fibroid agent: a perspective on protein networks, molecular docking, ADMET, simulation, DFT and bioactivity. Chemical Physics Impact 8:100412. https:\/\/doi.org\/10.1016\/j.chphi.2023.100412","journal-title":"Chemical Physics Impact"},{"key":"5145_CR18","doi-asserted-by":"publisher","DOI":"10.3390\/ph15050572","volume":"15","author":"F Noor","year":"2022","unstructured":"Noor F, Tahir Ul Qamar M, Ashfaq UA et al (2022) Network pharmacology approach for medicinal plants: review and assessment. Pharmaceuticals 15:572. https:\/\/doi.org\/10.3390\/ph15050572","journal-title":"Pharmaceuticals"},{"key":"5145_CR19","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/138460","volume":"2014","author":"S Li","year":"2014","unstructured":"Li S, Fan T-P, Jia W et al (2014) Network pharmacology in traditional Chinese medicine. Evid Based Complement Alternat Med 2014:138460. https:\/\/doi.org\/10.1155\/2014\/138460","journal-title":"Evid Based Complement Alternat Med"},{"key":"5145_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.648037","volume":"12","author":"Q Li","year":"2021","unstructured":"Li Q, Hu S, Huang L et al (2021) Evaluating the therapeutic mechanisms of selected active compounds in Cornus officinalis and Paeonia lactiflora in rheumatoid arthritis via network pharmacology analysis. Front Pharmacol 12:648037. https:\/\/doi.org\/10.3389\/fphar.2021.648037","journal-title":"Front Pharmacol"},{"key":"5145_CR21","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/S1875-5364(13)60037-0","volume":"11","author":"S Li","year":"2013","unstructured":"Li S, Zhang B (2013) Traditional Chinese medicine network pharmacology: theory, methodology and application. Chin J Nat Med 11:110\u2013120. https:\/\/doi.org\/10.1016\/S1875-5364(13)60037-0","journal-title":"Chin J Nat Med"},{"key":"5145_CR22","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0083922","volume":"8","author":"K-Y Hsin","year":"2013","unstructured":"Hsin K-Y, Ghosh S, Kitano H (2013) Combining machine learning systems and multiple docking simulation packages to improve docking prediction reliability for network pharmacology. PLoS ONE 8:e83922. https:\/\/doi.org\/10.1371\/journal.pone.0083922","journal-title":"PLoS ONE"},{"key":"5145_CR23","doi-asserted-by":"publisher","first-page":"7520","DOI":"10.1007\/s12010-023-04433-w","volume":"195","author":"CB Olowosoke","year":"2023","unstructured":"Olowosoke CB, Gbemisola O, Alaba AA et al (2023) Multi-regulator of EZH2-PPARs therapeutic targets: a hallmark for prospective restoration of pancreatic insulin production and cancer dysregulation. Appl Biochem Biotechnol 195:7520\u20137552. https:\/\/doi.org\/10.1007\/s12010-023-04433-w","journal-title":"Appl Biochem Biotechnol"},{"key":"5145_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.imu.2022.101137","volume":"35","author":"OA Ojo","year":"2022","unstructured":"Ojo OA, Ogunlakin AD, Iyobhebhe M et al (2022) Computer aided and experimental study of cinnamic acid analog for oxidative stress treatment: the therapeutic validations. Informatics in Medicine Unlocked 35:101137. https:\/\/doi.org\/10.1016\/j.imu.2022.101137","journal-title":"Informatics in Medicine Unlocked"},{"key":"5145_CR25","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1038\/s41401-022-00988-2","volume":"44","author":"Y Bang","year":"2023","unstructured":"Bang Y, Kwon Y, Kim M et al (2023) Ursolic acid enhances autophagic clearance and ameliorates motor and non-motor symptoms in Parkinson\u2019s disease mice model. Acta Pharmacol Sin 44:752\u2013765. https:\/\/doi.org\/10.1038\/s41401-022-00988-2","journal-title":"Acta Pharmacol Sin"},{"key":"5145_CR26","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.jchemneu.2015.12.002","volume":"71","author":"SN Rai","year":"2016","unstructured":"Rai SN, Yadav SK, Singh D, Singh SP (2016) Ursolic acid attenuates oxidative stress in nigrostriatal tissue and improves neurobehavioral activity in MPTP-induced Parkinsonian mouse model. J Chem Neuroanat 71:41\u201349. https:\/\/doi.org\/10.1016\/j.jchemneu.2015.12.002","journal-title":"J Chem Neuroanat"},{"key":"5145_CR27","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.tem.2018.11.003","volume":"30","author":"G Lin","year":"2019","unstructured":"Lin G, Wang L, Marcogliese PC, Bellen HJ (2019) Sphingolipids in the pathogenesis of Parkinson\u2019s disease and parkinsonism. Trends Endocrinol Metab 30:106\u2013117. https:\/\/doi.org\/10.1016\/j.tem.2018.11.003","journal-title":"Trends Endocrinol Metab"},{"key":"5145_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2020.109879","volume":"78","author":"ML Allende","year":"2021","unstructured":"Allende ML, Zhu H, Kono M et al (2021) Genetic defects in the sphingolipid degradation pathway and their effects on microglia in neurodegenerative disease. Cell Signal 78:109879. https:\/\/doi.org\/10.1016\/j.cellsig.2020.109879","journal-title":"Cell Signal"},{"key":"5145_CR29","doi-asserted-by":"publisher","first-page":"5436","DOI":"10.1007\/s12035-018-1448-3","volume":"56","author":"K Czubowicz","year":"2019","unstructured":"Czubowicz K, J\u0119\u015bko H, Wencel P et al (2019) The role of ceramide and sphingosine-1-phosphate in Alzheimer\u2019s disease and other neurodegenerative disorders. Mol Neurobiol 56:5436\u20135455. https:\/\/doi.org\/10.1007\/s12035-018-1448-3","journal-title":"Mol Neurobiol"},{"key":"5145_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/cells11081353","volume":"11","author":"A Esfandiary","year":"2022","unstructured":"Esfandiary A, Finkelstein DI, Voelcker NH, Rudd D (2022) Clinical sphingolipids pathway in Parkinson\u2019s disease: from GCase to integrated-biomarker discovery. Cells 11:1353. https:\/\/doi.org\/10.3390\/cells11081353","journal-title":"Cells"},{"key":"5145_CR31","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2018.00249","volume":"12","author":"A Di Pardo","year":"2018","unstructured":"Di Pardo A, Maglione V (2018) Sphingolipid metabolism: a new therapeutic opportunity for brain degenerative disorders. Front Neurosci 12:249. https:\/\/doi.org\/10.3389\/fnins.2018.00249","journal-title":"Front Neurosci"},{"key":"5145_CR32","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.brainresbull.2019.01.016","volume":"146","author":"HS Baul","year":"2019","unstructured":"Baul HS, Manikandan C, Sen D (2019) Cannabinoid receptor as a potential therapeutic target for Parkinson\u2019s disease. Brain Res Bull 146:244\u2013252. https:\/\/doi.org\/10.1016\/j.brainresbull.2019.01.016","journal-title":"Brain Res Bull"},{"key":"5145_CR33","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.595635","volume":"11","author":"F Patricio","year":"2020","unstructured":"Patricio F, Morales-Andrade AA, Patricio-Mart\u00ednez A, Lim\u00f3n ID (2020) Cannabidiol as a therapeutic target: evidence of its neuroprotective and neuromodulatory function in Parkinson\u2019s disease. Front Pharmacol 11:595635. https:\/\/doi.org\/10.3389\/fphar.2020.595635","journal-title":"Front Pharmacol"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05145-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05145-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05145-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T19:02:01Z","timestamp":1757790121000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05145-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,24]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["5145"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05145-4","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"type":"print","value":"0893-7648"},{"type":"electronic","value":"1559-1182"}],"subject":[],"published":{"date-parts":[[2025,6,24]]},"assertion":[{"value":"4 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Number"}},{"value":"Angel Godad, Richa Sawant, Akshata R. Pahelkar, Galvina Pereira: writing\u2014original draft; resources; conceptualization; and visualization. Sadhana Sathaye: writing\u2014review and editing; supervision; and conceptualization.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"CRediT Authorship Contribution Statement"}}]}}